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I. INTRODUCTION/BACKGROUND 
In February 2008, a Weston resident (Ms. Ann Marie Kreft) contacted the 
Massachusetts Department of Public Health (MDPH) Associate Commissioner and 
Director of the Bureau of Environmental Health (BEH) to report concerns regarding what 
she perceived to be an unusual number of children with a diagnosis of type 1 diabetes in 
the three communities of Weston, Wellesley and Newton.   The primary concerns 
focused on children with type 1 diabetes that lived within a few miles of each other in an 
area where Weston, Wellesley and Newton are contiguous. Additional concerns focused 
on the possible relationship to environmental exposure opportunities in those 
communities.   Residents expressed concern about a number of potential sources of 
environmental pollution in the area including the Charles River, former land use 
activities, and hazardous waste sites.  While diabetes is not a reportable disease in 
Massachusetts, the MDPH/BEH has developed a surveillance system through funding 
from the U.S. Centers for Disease Control and Prevention’s (CDC) Environmental Public 
Health Tracking (EPHT) program.  In 2006, MDPH was one of seven states to receive 
funds from the CDC to develop an environmental public health tracking system.   
II. METHODS FOR ANALYZING TYPE 1 DIABETES 
PREVALENCE 
To evaluate whether a cluster of type 1 diabetes might exist, it is necessary to first 
identify all children ages 0 through 19 from Weston, Wellesley or Newton with type 1 
diabetes to determine the prevalence in the three communities.  A disease cluster can be 
thought of as an unusual occurrence of a disease in space and time. To investigate a 
perceived disease cluster, the following questions are typically asked: 
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 Is there an excess number of individuals diagnosed with a disease versus what 
might be expected? 
 Is the disease occurring in an unusual age group? 
 Does the geographic distribution of place of residence (or, in some instances, 
place of employment for adults) for those diagnosed with the disease appear 
unusual? 
 Does residential history appear to play a role in the observed prevalence of the 
disease? 
 Is the prevalence of a known or potential risk factor for the disease (for 
example, family history) different in the population being studied than would 
be expected? 
 If there appears to be an excess, are there some shared exposures? 
 Is there a grouping of dates of diagnosis such that it is plausible that a 
common exposure might have contributed to the occurrence of the disease? 
Beginning in the 2007-2008 school year, the annual collection of diabetes 
prevalence data for children in grades Kindergarten through 8th grade was begun by the 
Massachusetts EPHT program. The source of the data is school health records for all 
public and private schools in Massachusetts serving grades K - 8 (approximate ages 5-
14). School nurses or administrative staff are requested to provide the number of children 
with diabetes in their school, enumerating whether a child has Type 1, Type 2, or an 
unknown type of diabetes. No personal identifiers such as name or street address of a 
child are provided to the MDPH.  Data collection for year 2 (2008-2009 school year) of 
the diabetes surveillance was enhanced in order to be able to estimate prevalence by 
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community of residence in addition to estimates by county locations of the schools.  The 
school nurse/administrator reports the city/town of residence of the student to allow for 
estimating the prevalence of diabetes by city/town.  For both the 2007-2008 and 2008-
2009 school years, participation of public and private schools was excellent with more 
than 99% of schools reporting. 
As mentioned, the Massachusetts EPHT diabetes surveillance program collects 
information on children in grades K – 8. For this investigation, these efforts were 
expanded to include children in pre-schools and high school.   
A.  Case Identification/Definition 
In addition to using the Massachusetts EPHT diabetes surveillance data, MDPH 
took a two-phased approach to identify the children and adolescents living in the 
communities of Weston, Wellesley, and Newton with a diagnosis of type 1 diabetes.  The 
first effort involved MDPH contacting the public school nurse leaders and private school 
nurses or administrators in the three communities to ask them to facilitate the mailing of a 
letter and consent form to the parents/guardians of children with type 1 diabetes. The 
consent form requested diagnosis-related information on the child/adolescent with type 1 
diabetes and, importantly, specific address information.  [The consent form stated that 
MDPH is bound by strict privacy regulations to protect the confidentiality of any 
personally-identifying information provided by the parent/guardian.] The second 
approach was to contact hospitals and endocrinologists in the area to provide MDPH with 
information on the number of children ages 0 through 19 who they treat from the three 
communities.  In addition, families who heard about the investigation from the media or 
another source (for example, a family whose child attended a private school outside one 
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of the three communities) also submitted consent forms and were included in the 
investigation if their child met the criteria for inclusion.   
1. Schools 
As mentioned, MDPH has been collecting information on the number of children 
in grades K-8 who have diabetes across the state with funding from the federal Centers 
for Disease Control and Prevention’s Environmental Public Health Tracking Program.  
MDPH has achieved a near 100% participation rate from school nurses and 
administrative staff in public and private schools across the state.  However, because 
residents are concerned about diagnoses in children of all ages, MDPH expanded their 
evaluation to include children ages 0 through 19 years.   
In spring 2009, MDPH worked with the Public School Nurse Leaders for each of 
the three communities to facilitate mailings to the parents/guardians of children in their 
schools with type 1 diabetes. Given the requirements imposed by the Family Educational 
Rights and Privacy Act (FERPA), it was necessary to ask school nurses and 
administrative staff to conduct the mailing; FERPA prevents public health officials from 
direct access to student records. In addition to working with the public schools, MDPH 
worked with school nurses or school administrators at the 27 private schools in the three 
communities to identify children with type 1 diabetes who were residents of these 
communities and attended private school.  MDPH sent out two rounds of letters (May 
2009 and February/April 2010) through the school nurses in an effort to capture all of the 
diagnoses.  In summary, the mailings went to public and private pre-schools, elementary 
schools, middle schools, and high schools in these communities. 
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Included in the mailings were a letter to the families from the nurse leaders, a 
letter from MDPH, and a consent form (see Appendix A).  The consent form requested 
limited diagnostic and residential history information from parents to assist BEH in better 
understanding the prevalence and geographic distribution of children with a diagnosis of 
type 1 diabetes in the three communities.  
Based on January 2009 information from the public school nurse leaders provided 
during the planning phase for the mailings, MDPH estimates that approximately 67 
families received letters and consent forms from public school nurses. Of the 65 consent 
forms received by MDPH, 59 forms reported that the child/adolescent attended a public 
school. For public school students, this represents an estimated response rate of 
approximately 88% (59 of 67). Using information from the EPHT Program, for children 
in grades K through 8, 42 children/adolescents from Weston, Wellesley, and Newton 
were reported with type 1 diabetes. MDPH received consent forms from 38 
parents/guardians in these communities. This represents a response rate of approximately 
90% (38 of 42). The actual response rate would not be expected to be higher and could be 
lower due to later diagnoses in 2009 (captured through late mailings by a 
nurse/administrator) and depending on the response of private school parents/guardians.  
2. Hospitals/Providers 
MDPH/BEH has worked with Dr. Lori Laffel, Chief of the Pediatric, Adolescent 
and Young Adult Section at the Joslin Diabetes Center since the earliest stages of this 
investigation.  As part of MDPH’s collaboration with Dr. Laffel, a survey for health care 
providers was developed.  The purpose was to identify all children/adolescents in the 
three communities with type 1 diabetes.  In April 2010, MDPH asked each physician via 
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a mailing to report a count of individuals with type 1 diabetes (ages 0 through 19) who 
were treated at their facility in calendar year 2009 and who were residents of one of the 
three communities.  MDPH provided the following International Classification of 
Diseases (ICD-9) codes to the providers for consistency in identifying cases of type 1 
diabetes (ICD-9 Codes-250.x1 and 250.x3). In all, eight treating facilities were contacted.  
The facilities included: Joslin Diabetes Center, Children’s Hospital, Massachusetts 
General Hospital, Boston Medical Center, BayState Medical Center, Tufts New England 
Medical Center, UMass Memorial Medical Center, and New England Diabetes and 
Endocrinology Center.  Initial and follow-up contact resulted in responses from all eight 
diabetes centers.   
B.  Estimating Prevalence  
Prevalence, for this report, is estimated based on the number of children and 
adolescents (ages 0-19) who had been diagnosed with type 1 diabetes by December 31, 
2009 and who were residents of either Weston, Wellesley, or Newton during the 2009 
calendar year. To determine whether the prevalence of type 1 diabetes in the three 
communities differs from what would be expected, data were tabulated to compare the 
community-specific prevalence estimates to statewide prevalence estimates (available 
through the MDPH EPHT Program) as well as national prevalence data (as reported in 
the SEARCH for Diabetes in Youth Study).  Further, to assess the prevalence of type 1 
diabetes in the area of particular concern to the residents, MDPH calculated census tract-
specific prevalence estimates.   
The SEARCH Study is a multicenter observational study that identifies all 
existing (prevalent) cases of nongestational diabetes (including type 1 and 2 diabetes), 
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beginning in 2001 and continuing through the present.  With a population of over 2 
million youth under surveillance for diabetes, the SEARCH Study represents the largest 
standardized registry of diabetes in U.S. youth.  A detailed description of the SEARCH 
Study has been published by the SEARCH Study Group (2004). Based on the 
demographics of Weston, Wellesley, and Newton, SEARCH prevalence estimates for 
non-Hispanic white youth with type 1 diabetes are used for comparison (Bell RA et al. 
2009). Approximately 89%, 88%, and 86% of the individuals residing in Weston, 
Wellesley, and Newton, respectively, are non-Hispanic whites (MAPC 2008). 
A CT is a geographic subdivision of a city or town designated by the United 
States Census Bureau.  Because age group and gender-specific population information is 
necessary to calculate prevalence estimates, the CT is the smallest geographic area for 
which disease estimates can be accurately calculated.  Specifically, a CT is a smaller 
statistical subdivision of a county as defined by the U.S. Census Bureau.  CTs usually 
contain between 1,500 and 8,000 persons and are designed to be homogenous with 
respect to population characteristics (U.S. Census Bureau 2000).  The town of Weston 
has two CTs, the town of Wellesley has six CTs, and the city of Newton has 18 CTs (see 
Figure 1). The three CTs that encompass the area of concern to residents include: 3672 
(Weston), 4042.01 (Wellesley), and 3748 (Newton) (see Figure 1). 
To calculate a prevalence estimate, it is necessary to obtain accurate population 
information.  The population figures used to calculate community-specific prevalence 
estimates were provided by each community using data collected from their annual 
census.  For calculating prevalence estimates at the census tract level, projected 
population data for 2010 were used which were obtained by MDPH from Geolytics 
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(2010); census-tract level data were not available from the communities.   
C.  Calculation of the 95% Confidence Interval 
To help assess the stability of a prevalence estimate, the statistical significance of 
each estimate was assessed by calculating a 95% confidence interval (95% CI) to 
determine if the prevalence estimate for a geographic region (i.e., community or census 
tract) is “significantly different” from the prevalence estimate in a comparison area (i.e., 
the state or the nation)1.  Specifically, a 95% CI is the range of estimated prevalence 
estimates that have a 95% probability of including the true prevalence estimate for the 
population.  If the confidence intervals of the two geographic areas do not overlap, then 
the prevalence estimate in the study population is considered to be statistically 
significantly different from the comparison or "normal" population. Using the state of 
Massachusetts or the United States as a comparison population provides a stable 
population base for the estimation of prevalence. "Statistically significantly different" 
means there is less than a 5% chance that the observed difference (either increase or 
decrease) in the estimate is due to chance (i.e., the result of random fluctuation in the 
number of individuals with type 1 diabetes).   
For example, if the confidence interval for the prevalence of type 1 diabetes 
among individuals in a given community is 2.7-2.9 cases per 1,000 children and the 
confidence interval for the state is 2.5-2.6 cases per 1,000 children, the prevalence of type 
1 diabetes in the community is considered to be statistically significantly higher than in 
the state as a whole. This is because the confidence intervals do not overlap.  If the 
confidence interval is 1.8-2.0 cases per 1,000 children in a community and the confidence 
                                                 
1 The Poisson distribution was used to calculate confidence intervals. 
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interval for the state is 2.5-2.6 cases per 1,000 children, the prevalence of type 1 diabetes 
diagnoses would be considered statistically significantly lower than expected, based on 
the statewide experience.  It is important to note that statistical significance alone does 
not necessarily imply public health significance.  Determination of statistical significance 
is just one tool used to interpret disease patterns in a community. 
In addition to the range of the estimates contained in the confidence interval, the 
width of the confidence interval also reflects the stability of the prevalence estimate.  For 
example, a narrow confidence interval allows a fair level of certainty that the estimated 
prevalence is close to the true prevalence for the population. A wide interval leaves 
considerable doubt about the true prevalence, which could be lower or higher than the 
estimated prevalence.  Wide intervals indicate unstable statistics.   
D.  Residential History and Geographic Distribution of Cases of 
Type 1 Diabetes 
In addition to calculating prevalence estimates, residential history information 
reported on the consent form for each individual diagnosed with type 1 diabetes was 
mapped using a computerized geographic information system (GIS) (ESRI 2009).  
Current address and address at diagnosis were mapped. This allowed for an evaluation of 
the spatial distribution of residences at a smaller geographic level within neighborhoods.  
The geographic pattern was assessed using a qualitative evaluation of the point pattern of 
diagnoses in the community.  This evaluation also included consideration of the 
population density of individuals less than 20 years of age residing within the three 
communities.  For confidentiality reasons, it is not possible to include maps showing the 
locations of residences for individuals diagnosed with type 1 diabetes in this report.  
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[Note: MDPH is bound by state and federal patient privacy and research laws not to 
reveal the name or any other identifying information of an individual diagnosed with type 
1 diabetes and reported to the MDPH.] 
Population density at the census block level for each of the three communities 
was calculated using the 2010 U.S. Census population estimates for individuals aged 0 – 
19 (Geolytics 2010)2. (Actual 2010 population counts were not available through the 
2010 U.S. Census at the time of this analysis.) Population density is presented as persons 
per square dry mile. Breakpoints for density divisions were assigned in each community 
using four quartiles. Census blocks with a population of zero individuals were excluded 
from the data presentation.  See Figures 2, 3, and 4 for maps of the population density of 
children and adolescents in Weston, Wellesley, and Newton.  
E. Family History 
The consent form asked parents/guardians if any other family members have been 
diagnosed with type 1 diabetes. This information allowed MDPH to compare the 
percentage of children and adolescents in Weston, Wellesley, and Newton who have a 
positive family history for type 1 diabetes with the percentage expected to have a positive 
family history, based on the epidemiologic literature. 
III. RESULTS 
As of June 2011, MDPH received 65 consent forms from the parents/guardians of 
children living in Weston, Wellesley and Newton who had been diagnosed with type 1 
                                                 
2 The population estimates were created using 2000 census block boundaries. 
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diabetes and were between 0 -19 years of age prior to December 31, 20093. The results 
from the health care provider survey identified 104 children, ages 0-19 years, from the 
three communities who were treated for type 1 diabetes during 2009 at the eight facilities 
contacted. (Section VII includes a discussion of these data sources and how their 
prevalence estimates may relate to the underlying true prevalence of type 1 diabetes in 
these communities.)   
A. General Participant Information 
 Summary participant information is provided in Table 1. This information was 
obtained from the 65 consent forms returned to MDPH.  The information in Table 1 does 
not represent all children/adolescents with type 1 diabetes in the three communities; those 
children/adolescents reported solely by the hospitals/providers and those whose 
parents/guardians chose not to return the consent form to MDPH could not be included in 
the summary participant information. In these three communities, 58% of the individuals 
with type 1 diabetes were reported to be females and 42% males.  Seventy percent of the 
individuals (45 of 65) aged 0-19 years with type 1 diabetes living in Weston Wellesley or 
Newton were less than 10 years of age at the time of their diagnosis.   Twenty-eight 
percent (18 of 65) were diagnosed between 0 - 4 years of age, 42% (27 of 65) between 5 
– 9 years of age, 29% (19 of 65) between 10 – 14 years of age, and 1% (1 of 65) between 
15 – 19 years of age.    
 Although providers were not asked to abstract medical records to report age at 
diagnosis, they did provide the breakdown of their patients by sex. Of the 104 
                                                 
3 Information for five individuals living in Wellesley was not included in this analysis.  Two were not 
included because they were older than 19 years of age prior to December 31, 2009 and three were 
diagnosed with diabetes after December 31, 2009.    
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children/adolescents from Weston, Wellesley, and Newton seen by providers in 2009, 46 
(44%) are male and 58 (56%) are female. The actual percentage of males versus females 
in this group could, however, be different because of the possibility of duplicate reports 
by providers.  
B. Prevalence Estimate Calculations for the Three Communities 
MDPH calculated prevalence estimates and 95% confidence intervals using three 
different data sources: 
 Consent form information reported to MDPH by parents/guardians of 
children/adolescents diagnosed with type 1 diabetes 
 Health care provider information on the number of children/adolescents who 
were with diagnosed with or sought care for type 1 diabetes at their facility in 
2009 
 Prevalence estimates from the MDPH Environmental Public Health Tracking 
Program 
Because each of these datasets differ with respect to the age group included 
and/or their likelihood of over- or under-estimating the true prevalence, MDPH has used 
the three datasets to provide a range of prevalence estimates. MDPH included the 
prevalence estimates based on data provided by school nurses to the EPHT program; 
more than 99% of public and private schools reported their data to MDPH, hence the data 
quality and completeness are very high and they provide a stable statewide prevalence 
estimate for comparison. Through the consent form and health care provider data, MDPH 
was able to expand the range of ages included to very young children (ages 0 – 4) and 
adolescents (ages 15 – 19), to supplement the EPHT dataset representing children in 
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grades K – 8 (approximately ages 5 – 14). (Please see the discussion section for further 
information about the strengths and limitations of these datasets.)  
Table 2 contains prevalence estimates for individuals ages 0-19 years for each 
community as a whole (using data from the consent forms and the health care provider 
surveys).  Table 3 contains prevalence estimates for individuals approximately ages 5-14 
years (using data from each of the three datasets). For comparison purposes, Tables 2 and 
3 also include national prevalence estimates from the SEARCH for Diabetes in Youth 
Study (Bell RA et al. 2009).    In addition to the SEARCH data, prevalence data for the 
state of Massachusetts as a whole, collected by the EPHT, are used for comparison 
purposes for the 5 – 14 age group. These statewide EPHT data include all races and 
ethnicities. As stated earlier, based on the percentage of non-Hispanic whites in Weston, 
Wellesley, and Newton (86 – 89%), national SEARCH data used for comparison in this 
report are for the non-Hispanic white population. For Massachusetts as a whole, based on 
2010 US Census data, white non-Hispanics comprise 76.1% of the population (US 
Census Bureau 2011a). 
Using both data sources reported in Table 2, the consent form information and the 
health care provider information, a range of prevalence estimates for each community can 
be used for comparison to the SEARCH Study prevalence estimate for the 0 – 19 age 
group: 
 Newton: 1.69 – 3.62 diagnoses per 1, 000 individuals (95% CI: 1.11 – 4.68) 
 Wellesley:  2.98 – 3.58 diagnoses per 1, 000 individuals (95% CI: 1.93 – 5.11) 
 Weston:  3.66 – 4. 50 diagnoses per 1, 000 individuals (95% CI: 1.95 – 7.31) 
 SEARCH Study:  2.00 diagnoses per 1, 000 individuals  (95% CI: 1.94 – 2.06)  
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Comparing the range of prevalence estimates to the point prevalence estimate provided 
by the SEARCH Study, it appears that the prevalence of type 1 diabetes in Newton 
approximates the prevalence nationwide; the SEARCH Study prevalence estimate of 2.00 
diagnoses per 1,000 individuals is in the middle of the range of prevalence estimates for 
Newton of 1.69-3.62 diagnoses per 1,000 individuals.  However, in Wellesley and 
Weston, the prevalence of type 1 diabetes appears to be higher than the nationwide 
prevalence.  These differences are not, however, statistically significant. This is indicated 
by the overlapping confidence intervals of each community with the confidence interval 
for the SEARCH Study.  The stability of the prevalence estimates is reflected by the 
width of their respective confidence intervals.  While the confidence interval for the 
SEARCH Study prevalence estimate is relatively narrow (1.94-2.06), the community-
specific confidence intervals reported above are much wider, reflecting greater instability 
in the prevalence estimates due to smaller population bases and fewer diagnoses. 
Based on the consent form information only, the same conclusions could be 
drawn as above (Table 2). When reviewing the data based on the health care provider 
information only, however, there were statistically significant differences in prevalence 
estimates for each of the three communities when compared to the national SEARCH 
data.  The prevalence of type 1 diabetes was statistically significantly higher in each 
community than in the nation as a whole.  
Table 3 contains prevalence estimates for children in the 5 to 14 age group for 
Weston, Wellesley, and Newton, Massachusetts as a whole, and the U.S. as a whole. The 
prevalence of type 1 diabetes in the state of Massachusetts as a whole (based on EPHT 
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data) is statistically significantly higher than the prevalence in the U.S. as a whole (based 
on SEARCH data).   
Using the three data sources reported in Table 3 - the consent form information, 
the health care provider information, and the EPHT data - a range of prevalence estimates 
for each community can be used for comparison to the statewide and national prevalence 
estimates for the 5 – 14 age group: 
 Newton: 2.27 – 3.71 diagnoses per 1, 000 individuals (95% CI: 1.37 – 5.27) 
 Wellesley:  2.53 – 3.44 diagnoses per 1, 000 individuals (95% CI: 1.26 – 5.68) 
 Weston:  3.83 – 4.45 diagnoses per 1, 000 individuals (95% CI: 1.53 – 8.45) 
 EPHTP statewide data:  2.53 diagnoses per 1,000 individuals (95% CI: 2.41 – 
2.65) 
 SEARCH Study:  2.12 diagnoses per 1, 000 individuals  (95% CI: 2.03 – 2.21)  
It appears that the prevalence of type 1 diabetes in Wellesley and Weston is higher than 
that in Massachusetts as a whole. These differences, however, are not statistically 
significant.  Based on a comparison of the confidence intervals around the prevalence 
point estimates, the prevalence of type 1 diabetes among individuals between the ages of 
5 and 14 years in each of the three communities does not appear to be statistically 
significantly different from that of similarly-aged children in Massachusetts statewide.   
 When compared to the SEARCH Study data for this age group, a statistically 
significant elevation in the prevalence of type 1 diabetes in Newton children ages 5 – 14 
was found when the health care provider information was used to estimate prevalence.  
Based on the consent form and EPHT data, however, the prevalence estimates for 
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Newton children ages 5 – 14 appear to be similar to the SEARCH Study data (as well as 
the statewide data).     
C.  Prevalence Estimate Calculations for the Census Tracts of 
Concern 
In addition to calculating prevalence estimates for the three communities, MDPH 
calculated prevalence estimates and 95% CIs for each of the three census tracts of 
concern (see Figure 1). The census tracts of concern include: 3672 (Weston), 4042.01 
(Wellesley), and 3748 (Newton). To protect privacy due to the small number of 
diagnoses in each CT, the number of diagnoses and prevalence estimate for the individual 
census tract could not be reported; however, the 95% confidence interval for each 
prevalence estimate can be provided without violating privacy rules. After reviewing the 
census tracts contiguous to the area of concern to some residents, MDPH decided to also 
include Wellesley census tract 4043.01 and Newton census tract 3747 in the evaluation. 
Table 4 contains the 95% confidence intervals for each of the five census tracts, and 
prevalence estimates and 95% confidence intervals for all five census tracts combined.   
 Using the address information provided in the participant consent forms, MDPH 
assigned a census tract location to each participant.  As previously mentioned, the health 
care providers reported counts of children with type 1 diabetes in each community but no 
personally-identifying information such as address.  Therefore, census tract-level 
prevalence estimates are based on consent form information only. 
 The prevalence estimate of type 1 diabetes among individuals aged 0-19 years in 
the five census tracts combined is higher than the national prevalence estimate. This 
elevation is statistically significant.  While prevalence estimates are not provided for the 
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five census tracts individually, the confidence interval for each CT is reported.  For three 
of the five CTs - two in Wellesley (4042.01 and 4043.01) and one in Weston (3672) - 
their confidence intervals do not overlap with the confidence interval for the SEARCH 
Study, representing statistically significant elevations in these three CTs.  The prevalence 
estimate for Newton CTs 3747 and 3748 are not statistically significantly different from 
the national prevalence estimate. It is important to note, however, that the confidence 
intervals for the 3 CTs are relatively wide indicating unstable statistics and increasing 
uncertainty about the true prevalence, which could be lower or higher than the calculated 
prevalence.   
IV. RESIDENTIAL HISTORY 
The consent form sent to families by the school nurse leaders in the three 
communities requested information pertaining to the family’s residential history from two 
years prior to the child’s birth to the time of their diagnosis.  Table 5 summarizes 
residential history information for the three communities. Ten of the 65 (15%) 
children/adolescents were diagnosed with type 1 diabetes while living in a community 
other than Weston, Wellesley or Newton at the time of their diagnosis.  (Three of the 10 
individuals reported previously living in one of these three communities prior to 
diagnosis, but not at the time of diagnosis.)  Fifty-five (85%) children/adolescents were a 
resident of Weston, Wellesley, or Newton at the time of their diagnosis. Thirty-six of the 
65 (55%) children/adolescents have lived in Weston, Wellesley or Newton their entire 
lives.  Of these 36, one or both parents of 21 of the children/adolescents also lived there 
for one to two years prior to their child’s birth.   
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Table 6 summarizes residential history information for the census tracts in 
Weston, Wellesley, and Newton. Four of the 30 (13%) children/adolescents were 
diagnosed with type 1 diabetes while living outside one of the five census tracts.  
Twenty-six (87%) children/adolescents were a resident of one of the five census tracts at 
the time of their diagnosis. Seventeen of the 30 (57%) children/adolescents have lived in 
one of the five census tracts their entire lives.  Of these 17, one or both parents of 8 of the 
children/adolescents also lived there for one to two years prior to their child’s birth.   
V. FAMILY HISTORY 
In addition to residential history, parents reported information about the family’s 
history of type 1 diabetes on the consent forms (Tables 5 and 6).  Of the 65 families with 
a child or adolescent with type 1 diabetes within the three communities, 21 families 
(32%) reported that their child has another family member with a history of type 1 
diabetes.  Eight of the 65 children/adolescents were reported to have a parent (7 fathers 
and 1 mother) with type 1 diabetes.  (Of these eight individuals, three were also reported 
to have a sibling with type 1 diabetes and two were reported to have another family 
member with type 1 diabetes.)  An additional two of the 65 children/adolescents were 
reported to have a sibling with type 1 diabetes, making a total of five sibling pairs with 
type 1 diabetes.  Eleven of the 65 children/adolescents were reported to have another 
relative (not immediate) with type 1 diabetes (with two of these individuals having more 
than one relative with type 1 diabetes).  Forty-four children/adolescents were reported to 
have no family member with type 1 diabetes.   
Within the five census tracts, of the 30 families with a child or adolescent with 
type 1 diabetes, 11 children’s families (37%) reported that their child has another family 
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member with a history of type 1 diabetes.  Of these 11, two were reported to have a 
parent, two were reported to have a sibling, and seven were reported to have another 
relative (not immediate) with type 1 diabetes.  Nineteen (63%) children/adolescents were 
reported to have no family member with type 1 diabetes.   
VI. GEOGRAPHIC DISTRIBUTION OF RESIDENCE AT 
DIAGNOSIS 
In addition to calculating prevalence estimates, MDPH staff mapped address 
information reported on the consent forms for individuals diagnosed with type 1 diabetes 
using a computerized geographic information system (GIS) (ESRI 2009).  Current 
address was mapped for the children/adolescents with type 1 diabetes who reside in one 
of the three communities and address at the time of diagnosis was mapped for those 
individuals who lived in one of the three communities at the time of their diagnosis.  
Mapping address information allows for an evaluation of the spatial distribution of the 
residences of children/adolescents living with type 1 diabetes, and thus a qualitative 
evaluation of the point pattern of type 1diabetes diagnoses in the communities.   
 To evaluate the spatial pattern of type 1 diagnoses, the population density of the 
children and adolescent population (aged 0 -19) in Weston, Wellesley, and Newton was 
compiled and GIS-generated population density overlay maps were developed.   
MDPH staff reviewed the spatial pattern of address prior to diagnosis or at 
diagnosis for the 55 children who resided in Weston, Wellesley, or Newton at the time of 
their diagnosis and whose parents/guardians provided consent forms to MDPH.  If an 
environmental factor or factors were potentially playing a role in the development of type 
1 diabetes in children in these communities, it is important to review address information 
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prior to diagnosis and up to the time of the child’s diagnosis.  In general, the spatial 
pattern of address at diagnosis did not reveal any unusual patterns. As would be expected, 
areas where more children lived when diagnosed with type 1 diabetes were the same 
areas in the communities with higher numbers of children residing in those census blocks 
(i.e., areas of greater population density).    
VII. DISCUSSION 
Type 1 diabetes (also called juvenile-onset diabetes mellitus and insulin-
dependent diabetes mellitus) is caused by an absolute insulin deficiency, the result of a 
loss of the insulin-producing beta cells of the pancreas.  Type 1 diabetes is the most 
common type of diabetes in children, but it can develop in individuals at any age.  
Researchers estimate that about one in every 400-600 individuals under 20 years of age in 
the U.S. has type 1 diabetes (American Diabetes Association 2011, Children’s Hospital 
Boston 2011).  Children are most commonly diagnosed during puberty, around 10 to 12 
years of age in girls, and around 12 to 14 years of age in boys.  In recent years, the 
incidence of type 1 diabetes has been increasing in children less than five years of age.  
According to information from the Joslin Diabetes Center, approximately 5 - 10% of 
children with type 1 diabetes have another family member who also has the disease 
(Laffel, Dr. Lori 2011).  Brothers and sisters of children with type 1 diabetes have about a 
10 percent chance of developing the disease by age 50. The identical twin of a person 
with type 1 diabetes has a 25 to 50 percent chance of developing type 1 diabetes 
(Children’s Hospital Wisconsin 2011).    
Type 1 diabetes is an autoimmune disease that develops in genetically susceptible 
individuals whose immune cells (T lymphocytes) infiltrate the pancreas and destroy 
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insulin-producing beta cells. HLA (human leukocyte antigen) genes account for between 
30 and 50% of the genetic risk for type 1 diabetes while non-HLA genes and/or a shared 
environment account for the other half (Knip M et al. 2005; Steck AK and Rewers MJ 
2011).  Children with two particular HLA-risk genotypes (DR3/4-DQ8 or DR4/DR4) 
who have a family history of type 1 diabetes have more than a 1 in 5 risk for developing 
islet autoantibodies during childhood, and children with the same high-risk genotypes but 
no family history have approximately a 1 in 20 risk (Steck AK and Rewers MJ 2011.)  Of 
those individuals with HLA-conferred predisposition to type 1 diabetes, approximately 
5% are thought to progress to overt type 1 diabetes across the lifespan (Knip M et al. 
2005).   
The clinical presentation of type 1 diabetes is preceded by a period with no 
symptoms of the disease; this period can range from a few months to years.  The 
appearance of diabetes-associated autoantibodies, of which there are five types, is the 
first detectable or measurable sign of the autoimmune disease process, which may or may 
not lead to clinical disease (Laffel L 2011; Knip M et al. 2005). The likelihood of 
developing the disease is correlated with the number of detectable autoantibodies. 
The National Institute of Environmental Health Sciences (NIEHS) reports that 
almost all diseases result from a complex interaction between an individual’s genetic 
make-up and environmental agents, where an environmental agent is defined as anything 
outside the body, including food, medicines or pharmaceutical agents, bacteria and 
viruses, and the physical and built environment (both indoor and outdoor). Subtle 
differences in genetic factors cause people to respond differently to the same 
environmental exposure. This explains why some individuals have a fairly low risk of 
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developing a disease as a result of an environmental insult, while others are much more 
vulnerable (NIEHS 2011).  Researchers now think that multiple environmental factors 
including infections and diet may raise or lower the risk of developing diabetes 
throughout the period before the onset of type 1 diabetes (Dinsmoor RS 2006).  While it 
used to be thought that type 1 diabetes was an acute onset disease in children, that 
thinking is no longer the case.  Type 1 diabetes is now thought to be a multi-factorial, 
multi-stage disease. Most children are thought to have islet cell antibodies for perhaps 
several years before disease onset. 
 A range of prevalence estimates from three data sources was used to estimate 
prevalence. The role of possible under- and over-reporting of diagnoses should be 
considered for each data source.  Because of its near 100% completeness, the data for the 
5 – 14 age group collected by the school nurses as part of the Environmental Public 
Health Tracking Program can be used for evaluation of under- and/or over-reporting for 
the information received from the consent forms and from the health care providers (see 
Table 7). From the data in Table 7 for the 5 to 14 age group, it appears that counts based 
on the consent forms may be somewhat low while counts based on the health care 
provider forms are likely to be high.  This is consistent with what would be expected.  A 
few families with children with type 1 diabetes chose not to participate and did not return 
the consent form. However, we might expect some reporting bias by persons responding 
by the consent form. For example, families with a positive family history of type 1 
diabetes or families with children diagnosed at very young ages, who by definition have 
demanding disease, may be more likely to submit the consent form than other families 
with sporadic disease or those whose child had an older age of onset of type 1 diabetes. 
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Such possible reporting bias may account for the high proportion of families with a 
positive family history of diabetes.  
With respect to the health care provider information, it is not unusual for a child 
to be treated for type 1 diabetes at more than one health care institution over the course of 
a year. Their initial diagnosis may occur at one institution and follow-up care may occur 
at another institution. A child who visited more than one health care provider in 2009 
would have been counted more than once. Therefore, the health care provider prevalence 
estimates most likely are over-estimates of the true prevalence.  
The SEARCH for Diabetes in Youth Study reported that the prevalence of type 1 
diabetes in non-Hispanic white youth aged 0 – 19 years was 2.00/1000, which was 
similar for males (2.02/1000) and females (1.97/1000) (Bell RA et al. 2009). This sex 
distribution is consistent with our statewide EPHT data. For the 2008-2009 school year, 
the number of male versus female children/adolescents in grades K through 8 with type 1 
diabetes was approximately the same: 883 males versus 879 females. Based on the 
consent form information for the 65 children/adolescents aged 0 – 19 years in Weston, 
Wellesley, and Newton with type 1 diabetes, 27 (42%) are males and 38 (58%) are 
females. Although based on national and statewide data we would expect the prevalence 
of type 1 diabetes to be very similar in males and females, with a slightly higher 
prevalence in males, this is not the case in Weston, Wellesley, and Newton. The 
prevalence in these three communities, based on the consent form data, appears to be 
higher in females than males. 
Based on the EPHT data for children in the 5 to 14 age group, we reported that the 
prevalence of type 1 diabetes in the state of Massachusetts as a whole is statistically 
  24
significantly higher than the prevalence in the U.S. as a whole (based on SEARCH data). 
One possible explanation for this is the difference in percentage of non-Hispanic whites 
in Massachusetts than in the U.S. From the SEARCH study, we know that the prevalence 
of type 1 diabetes is highest in non-Hispanic white youth, followed by Black, Hispanic, 
American Indian, and Asian Pacific Islander youth (Liese AD et al. 2006).  As stated 
earlier, based on 2010 US Census data, white non-Hispanics constitute 76.1% of the 
population in Massachusetts compared to 63.7% of the U.S. population (U.S. Census 
Bureau 2011b). 
 According to the Joslin Diabetes Center (Laffel, Dr. Lori 2011), about five to ten 
percent of individuals who are diagnosed with type 1 diabetes have a family history of 
diabetes.  Of the 65 children/adolescents residing in Weston, Wellesley, or Newton and 
reported by their parents/guardians to have been diagnosed with type 1 diabetes, 21 
(32%) reported a family history of type 1 diabetes.  Dr. Lori Laffel has reported that 
about 5% of individuals diagnosed with type 1 diabetes have a first-degree relative 
(parent or sibling) with type 1 diabetes (Personal Communication, March 8, 2011).  Of 
the 65 children/adolescents residing in Weston, Wellesley, or Newton and reported by 
their parents/guardians to have been diagnosed with type 1 diabetes, 10 (15%) reported 
that a parent or sibling had been diagnosed with type 1 diabetes.  Of the eight 
children/adolescents that have a parent with type 1 diabetes, seven have a father with a 
previous diagnosis of type 1 diabetes.  For the five census tracts in Weston, Wellesley 
and Newton, 11 (37%) reported a family history of type 1 diabetes, four (13%) have a 
first-degree relative with type 1 diabetes, and two (7%) reported that a parent had been 
diagnosed with type 1 diabetes.  Epidemiologic data have suggested that the risk of type 1 
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diabetes developing by age 20 in the offspring of fathers with type 1 diabetes is about 
three times the risk of type 1 diabetes developing in the offspring of mothers with type 1 
diabetes (Warram JH et al. 1984; Warram JH et al. 1988). Based on these data, it appears 
that a family history of type 1 diabetes may have played more of a role in the prevalence 
of type 1 diabetes in Weston, Wellesley, and Newton, as well as in the five census tracts 
in Weston, Wellesley and Newton, than in the general population.  
VIII. CONCLUSIONS 
The following are the major conclusions from this investigation: 
  The prevalence of type 1 diabetes in children and adolescents at the 
community level in Weston, Wellesley, and Newton is not statistically 
significantly different from the nationwide prevalence estimates provided by 
the SEARCH Study or the statewide prevalence estimates provided by the 
MDPH/BEH Environmental Public Health Tracking Program.  
 Prevalence estimates for the three census tracts in Weston and Wellesley 
(3672, 4042.01, and 4043.01) are statistically significantly higher than the 
national prevalence estimate. This is not true for the Newton census tracts of 
3747 and 3748. 
 Based on information reported on the parent/guardian consent forms, it 
appears that family history of type 1 diabetes may have played more of a role 
in the prevalence of type 1 diabetes in Weston, Wellesley, and Newton as well 
as in the five census tracts, than in the general population. While nationally 
about 5 to 10% of individuals who are diagnosed with type 1 diabetes would 
be expected to have a family history of diabetes, 32% of the 
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children/adolescents in Weston, Wellesley, and Newton and 37% of the 
children/adolescents in the five census tracts in Weston, Wellesley, and 
Newton with type 1 diabetes were reported to have a family history of type 1 
diabetes. 
 Eighty-five percent of the children/adolescents diagnosed with type 1 diabetes 
resided in Weston, Wellesley or Newton at the time of their diagnosis. Within 
the five census tracts in Weston and Wellesley, 87% percent resided in their 
census tract at the time of their diagnosis. 
IX. RECOMMENDATIONS 
 MDPH will complete its review of environmental sites (that is, sites regulated 
under M.G.L. c. 21E) in the three census tracts in Wellesley and Weston 
(3672, 4042.01, and 4043.01) to evaluate the potential for exposure to 
contaminants associated with these sites and any potential relationship to 
disease prevalence. Particular attention will be paid to any environmental 
patterns that may emerge suggesting that children who may already be at 
higher risk of developing type 1 diabetes share more common opportunities 
for environmental exposure(s). 
 MDPH will evaluate on a statewide basis the variability in the prevalence of 
type 1 diabetes by examining the Environmental Public Health Tracking data 
(for grades K – 8) to identify areas with greater than and less than expected 
prevalence.  
 The findings from this report coupled with the findings from the 
environmental site reviews will direct follow-up investigative efforts.  
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Total 0-4 years 5-9 years 10-14 years 15-19 years
Sex (M/F) 27/38 1/0 3/7 14/14 9/17
Age at diagnosis - Count (%) 65 (100%) 18 (28%) 27 (42%) 19 (29%) 1 (1%)
Average age at diagnosis (Range <1-16) 7.2 -- -- -- --
1 Total number of participants = 65
Ages (Years)
Number of Participants1 (Percentages)
Table 1. Participant Information from Consent Forms 
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Table 2. Prevalence Estimates of Type 1 Diabetes in Children/Adolescents Ages 0-19 Years in Weston, Wellesley, and 
Newton as of December 31, 2009 
Count Prevalence per 1,000 95% CI Count Prevalence per 1,000 95% CI
Newton 27 1.69 (1.11, 2.45) 58 3.62 (2.75, 4.68)
Count Prevalence per 1,000 95% CI Count Prevalence per 1,000 95% CI
Wellesley 25 2.98 (1.93, 4.40) 30 3.58 (2.41, 5.11)
Count Prevalence per 1,000 95% CI Count Prevalence per 1,000 95% CI
Weston 13 3.66 (1.95, 6.25) 16 4.50 (2.57, 7.31)
Count Prevalence per 1,000 95% CI
United States 4045 2.00 (1.94, 2.06)
SEARCH Study
Consent Forms Provider Response
Consent Forms Provider Response
Consent Forms Provider Response
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Count Prevalence per 1,000 95% CI Count Prevalence per 1,000 95% CI Count Prevalence per 1,000 95% CI
Newton 19 2.27 (1.37, 3.55) 31 3.71 (2.52, 5.27) 22 2.38 (1.38, 3.37)
Wellesley 11 2.53 (1.26, 4.52) 15 3.44 (1.93, 5.68) 13 3.07 (1.63, 5.25)
Weston 8* 3.95 (1.71, 7.79) 9 4.45 (2.03, 8.45) 7* 3.83 (1.53, 7.88)
Count Prevalence per 1,000 95% CI
Massachusetts 1761 2.53 (2.41, 2.65)
Count Prevalence per 1,000 95% CI
United States 2201 2.12 (2.03, 2.21)
SEARCH Study
EPHTP
Consent Forms Provider Response EPHTP
Table 3. Prevalence Estimates of Type 1 Diabetes in Children/Adolescents Ages 5-14 Years in Weston, Wellesley, and 
Newton as of December 31, 2009 
 
*The additional Weston child/adolescent reported to MDPH via the consent forms may have been diagnosed with type 1 diabetes after the Weston 
school nurse reported the number of diagnoses to the EPHTP. 
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Census Tract Count Prevalence per 1,000 95% CI
Newton 3747 * * (0.02, 6.04)
Newton 3748 * * (0.02, 4.83)
Wellesley 4042.01 * * (4.03, 18.39)
Wellesley 4043.01 * * (3.86, 14.81)
Weston 3672 * * (2.43, 9.31)
All 5 Combined 30 4.88 (3.29, 6.96)
National SEARCH Study
4045 2.00 (1.94, 2.06)
*Due to the small numbers, counts and prevalence estimates are not reported to protect individuals' privacy.
Table 4. Prevalence Estimates of Type 1 Diabetes in Children/Adolescents Ages 0-19 Years in Selected Census Tracts in 
Weston, Wellesley, and Newton as of December 31, 2009 
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Residential History Count Percentage
Lived Outside Weston, Wellesley, and 
Newton at Time of Diagnosis
10 15
Lived in Weston, Wellesley, or 
Newton at Time of Diagnosis
55 85
Child/Adolescent has lived in Weston, 
Wellesley, or Newton their entire life 15 23
Child/Adolescent has lived in Weston, 
Wellesley, or Newton their entire life 
AND Parent(s) resided in Weston, 
Wellesley, or Newton within 1 to 2 
years of child’s birth
21 32
Family History of Type 1 Diabetes Count Percentage
Some Family Member 21 32
Mother or Father 8 12
Sibling 2 3
Other Relative 11 17
No Family Member/Relative 44 68
Table 5. Residential and Family History Information from Consent Forms for 3 Communities 
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Residential History Count Percentage
Lived Outside Weston, Wellesley, and 
Newton at Time of Diagnosis
4 13
Lived in Weston, Wellesley, or 
Newton at Time of Diagnosis
26 87
Child/Adolescent has lived in Weston, 
Wellesley, or Newton their entire life 9 30
Child/Adolescent has lived in Weston, 
Wellesley, or Newton their entire life 
AND Parent(s) resided in Weston, 
Wellesley, or Newton within 1 to 2 
years of child’s birth
8 27
Family History of Type 1 Diabetes Count Percentage
Some Family Member 11 37
Mother or Father 2 7
Sibling 2 7
Other Relative 7 23
No Family Member/Relative 19 63
 
Table 6. Residential and Family History Information from Consent Forms for 5 Census Tracts 
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Consent Forms EPHTP Provider Response
Newton 19 22 31
Wellesley 11 13 15
Weston 8 8 9
Table 7. Counts of Type 1 Diabetes Diagnoses in Children Ages 5 -14 in Weston, Wellesley, and Newton as of December 
31, 2009 
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Consent to Participate in Investigation of Type 1 Diabetes  
In Weston, Wellesley and Newton 
 
By signing the consent form below, you are agreeing to provide MDPH with diagnostic information 
about your child’s diabetes as well as residential history information.  In addition, you may choose to 
be contacted by MDPH as part of any future investigations of type 1 diabetes.  Your participation in 
this investigation is completely voluntary and you can withdraw at any time.  Please be assured that all 
information collected is considered confidential and will be protected under the Commonwealth’s 
privacy laws.  It is also important to note that MDPH staff have no current knowledge that you 
received this letter nor will they unless you return the consent form to MDPH agreeing to participate. 
 
I voluntarily consent to my participation in the Investigation of Type 1 Diabetes in Weston, Wellesley 
and Newton.  Please complete this page and the form on the back of this page. 
______________________________________________________________________________ 
Name of Child        
 
 Parent/Guardian Name      Relationship to Child   
______________________________________________________________________________ 
Parent/Guardian Current Address  Community   State  Zip Code 
 
 Signature of Parent/Guardian       Date 
 
Signature of MDPH Investigator   Print Name   Date 
 
The Commonwealth of Massachusetts 
Executive Office of Health and Human Services 
Department of Public Health 
Bureau of Environmental Health 
250 Washington Street, Boston, MA 02108-4619 
Phone: 617-624-5757 Fax: 617-624-5777 
TTY:  617-624-5286  DEVAL L. PATRICK 
GOVERNOR 
TIMOTHY P. MURRAY 
LIEUTENANT GOVERNOR 
JUDYANN BIGBY, M.D. 
SECRETARY 
JOHN  AUERBACH 
COMMISSIONER 
   
  42
Consent Form, MPDH Investigation of Type I Diabetes in Weston, Wellesley, and Newton 
GENERAL INFORMATION 
Child's Name:  
  
Current Address:  
  
  
Date of Birth:     /       / 
  
Gender (please check one): □ Male □ Female 
  
School Attending:  
  
Current Grade Level:  
DIAGNOSIS INFORMATION 
Age at Diagnosis:  
  
Address at Diagnosis:  
  
  
Is your child currently on 
insulin: □ Yes □ No 
  
Has your child been off insulin 
since his/her diagnosis: □ Yes □ No 
  
Have any of the following 
family members been 
diagnosed with type 1 
diabetes? 
Please check all that apply 
□ Mother □ Father □ Sibling □ Other ____________ 
Please list all residences of 
child, from 2 years prior to 
birth  to diagnosis, and 
dates of residences: Address: 
Date moved 
in: 
Date moved 
out: 
    
    
    
    
    
Please use the back of this form if more space is needed. 
 
Please check the box and sign below if you wish to be contacted by MDPH for any additional 
future investigation of type 1 diabetes.   
 
  
 Parent/Guardian Signature Date 
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Thanks you taking the time to complete this brief survey.  Please return it to MDPH in the envelope 
provided.   
 
PHYSICIAN SURVEY 
 
Name of Reporting Party:  
Best contact at your facility for follow-up: 
Preferred Contact Method (email or phone): 
Date: 
Please provide a count of individuals with type 1 diabetes (ages 0 through 19) who you 
have treated in calendar year 2009 who reside in the three communities listed below 
(ICD-9 Codes-250.x1 and 250.x3)4. Please place in the age category as of 2009: 
Age Groups 0-4 Years 5-9 Years 10-14 Years 15-19 Years 
Number of individuals treated:  M       F M       F M       F M       F 
Weston5  M       F M       F M       F M       F 
Wellesley6 M       F M       F M       F M       F 
Newton7 M       F M       F M       F M       F 
 
 
 
 
 
 
 
 
 
 
                                                 
4 To assist in you search, here are current zip codes for the 3 communities: 
Weston-02493 
Wellesley-02457, 02481, 02482 
Newton-02456, 02458, 02459, 02460, 02461, 02462, 02464, 02465, 02466, 02467, 02468, 
02495  
  
5 Former Weston zip code 
 02193 
 
6 Former Wellesley zip codes 
 02157, 02181, 02182 
 
7 Former Newton zip codes  
 02158, 02159, 02160, 02161, 02162, 02164, 02165, 02166, 02167, 02168, 02195 
 
